-
Thematic Analysis
NewComponent Makers Sector Scorecard, Q1 2024 Update – Thematic Intelligence
The component makers sector continues to struggle in the face of some significant challenges. Demand is anemic in two major areas for components: smartphones and electric vehicles (EVs). Both areas require customer investment that is not forthcoming in the face of a credit crunch caused by interest rate rises. Marginal upgrades for mobile phones and EVs that are too expensive for most means limited demand. There is light at the end of the tunnel in the industrial sector, where demand...
-
Thematic Analysis
NewCloud Gaming – Thematic Intelligence
Cloud Gaming Thematic Report Overview Cloud gaming allows video games to be streamed directly from the cloud and played using any device with a display and an internet connection. Its ease of use and flexibility will transform how games are distributed, consumed, and monetized. Cloud gaming’s success depends on the availability of reliable, fast networks, large game libraries, and competitive pricing. Some companies will use ad or usage-based plans to attract casual users. However, data privacy and copyright issues must...
-
Product Insights
Likelihood of Approval Analysis for Lennox-Gastaut Syndrome
Overview How likely is it that the drugs in Lennox-Gastaut Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lennox-Gastaut Syndrome Overview Lennox-Gastaut syndrome (LGS) is a severe form of epilepsy...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-20062 in Pertussis (Whooping Cough)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-20062 in Pertussis (Whooping Cough) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-20062 in Pertussis (Whooping Cough) Drug Details: LR-20062 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-20062 in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-20062 in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-20062 in Hepatitis B Drug Details: LR-20062 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-20062 in Poliomyelitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-20062 in Poliomyelitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-20062 in Poliomyelitis Drug Details: LR-20062 is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-20062 in Tetanus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-20062 in Tetanus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-20062 in Tetanus Drug Details: LR-20062 is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-20062 in Diphtheria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-20062 in Diphtheria report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-20062 in Diphtheria Drug Details: LR-20062 is under development for the prevention...
-
Track & Monitor
NewArtificial Intelligence in Retail: Planogram modelling
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the retail industry’s Planogram modelling segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-19123 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-19123 in Type 2 Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-19123 in Type 2 Diabetes Drug Details: LR-19123 is under...